The International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) has announced that Kindeva Drug Delivery Global Respiratory Product Development Manager Mike Needham will serve as Vice Chair of the IPAC-RS board until June 1, 2022 and will then take over as Chair, succeeding Carla Vozone of Catalent Pharma Solutions who will become Chair Emeritus for 2022-2024. Jennifer Wylie, Director in the Analytical Research and Development department at Merck Research Labs, is scheduled to succeed Needham as Vice Chair this year and then as Chair in June 2024.
Vozone commented, “It is truly an honor to congratulate Mike Needham and Jennifer Wylie on being elected as Chair and Vice Chair of IPAC-RS. Mike and Jen have been dedicated leaders as board members and I am confident they will build on the legacy of previous leadership and will expand the impact of the industry consortium in advancing regulatory science for orally inhaled and nasal products. Serving as Chair of IPAC-RS has been one of the most rewarding experiences of my career and I would like to express my gratitude to industry experts who continue to deliver projects that increase the collective knowledge of CMC aspects in OINDPs, collaborate with global regulatory agencies and create education resources for the industry.”
Needham said, “I look forward to helping IPAC-RS remain the leading voice of the global orally inhaled and nasal drug product (OINDP) industry. These past two years have highlighted the criticality of OINDPs and the companies that develop and manufacture these medical products. IPAC-RS will continue its important efforts to advance the global regulation and science of OINDPs and further its dedication to constructive collaboration with the broader OINDP community. I look forward to serving the IPAC-RS board and working closely with leaders from industry, academic research institutions, and global regulatory authorities in advancement of patient care.”
Wylie added, “I am honored to serve as IPAC-RS Vice Chair and to work closely with in-coming Chair, Mike Needham and current Chair, Carla Vozone. I have always been impressed with the breadth of initiatives that IPAC-RS sponsors – from its regulatory outreach groups that span agencies around the world to its numerous scientific and technical working groups focused on advancing the best science. IPAC-RS’s initiatives produce results that are relevant, timely and important. I am eager to help advance IPAC-RS’ strategic plan, including increasing collaboration with a broader range of stakeholders in the OINDP community.”
Read the IPAC-RS press release.
